Brookstone Capital Management Sells 56,464 Shares of CVS Health Corporation $CVS

Brookstone Capital Management cut its holdings in shares of CVS Health Corporation (NYSE:CVS) by 63.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 31,832 shares of the pharmacy operator’s stock after selling 56,464 shares during the period. Brookstone Capital Management’s holdings in CVS Health were worth $2,400,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CVS. Norges Bank acquired a new position in shares of CVS Health during the second quarter worth $1,358,698,000. Invesco Ltd. increased its holdings in CVS Health by 15.3% in the second quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock valued at $1,623,270,000 after purchasing an additional 3,118,626 shares during the period. Robeco Institutional Asset Management B.V. raised its position in CVS Health by 815.2% during the 2nd quarter. Robeco Institutional Asset Management B.V. now owns 2,663,111 shares of the pharmacy operator’s stock worth $183,701,000 after purchasing an additional 2,372,121 shares during the last quarter. Kingstone Capital Partners Texas LLC acquired a new position in CVS Health during the 2nd quarter worth about $155,185,000. Finally, Jennison Associates LLC increased its stake in shares of CVS Health by 111.7% in the second quarter. Jennison Associates LLC now owns 4,014,139 shares of the pharmacy operator’s stock valued at $276,895,000 after buying an additional 2,117,798 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts recently commented on the company. Weiss Ratings reiterated a “hold (c-)” rating on shares of CVS Health in a report on Monday, December 22nd. JPMorgan Chase & Co. boosted their price target on shares of CVS Health from $93.00 to $101.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 17th. Leerink Partners upped their price objective on shares of CVS Health from $86.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, October 16th. Truist Financial set a $100.00 target price on shares of CVS Health in a research note on Wednesday, December 10th. Finally, Wolfe Research boosted their target price on shares of CVS Health from $85.00 to $100.00 and gave the company an “outperform” rating in a report on Monday, December 8th. Two research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $94.67.

CVS Health Stock Up 0.6%

Shares of NYSE CVS opened at $79.60 on Friday. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. The firm has a market cap of $101.04 billion, a PE ratio of 209.47, a P/E/G ratio of 0.79 and a beta of 0.48. The company’s fifty day simple moving average is $78.91 and its 200 day simple moving average is $72.96. CVS Health Corporation has a 12-month low of $43.65 and a 12-month high of $85.15.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.24. The firm had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The business’s revenue was up 7.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, sell-side analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.